<< The Coalition Against Lyme and Related Borrelioses (CALRB,www.calrb.org) held a symposium today at the State Capitol building in Hartford, Conn., to discuss new DNA sequencing based approaches to Lyme disease testing and diagnosis. The symposium is believed to be the first of its kind devoted strictly to discussing these new and evolving DNA based testing techniques.
“The symposium is a call to action in response to a recent desire expressed by Dr. Paul Mead, chief of epidemiology and surveillance for the CDC’s Lyme disease program, for more reliable and conclusive Lyme disease tests,” said Kevin Moore, president and executive director of CALRB, adding, “This symposium hopefully gets us one step closer to newer, more effective tests.” >>
